106Indexed trials
mesh condition
Multiple Sclerosis
Intelligence
Multiple Sclerosis intelligence: 106 indexed trials, 24 recruiting studies, 81 sponsors across 59 countries.
24Recruiting
81Sponsors
59Countries
Leading sponsors
Teva Neuroscience, Inc.40 recruiting
Celgene40 recruiting
Biogen40 recruiting
University Hospital, Basel, Switzerland32 recruiting
Hoffmann-La Roche31 recruiting
NYU Langone Health20 recruiting
Insel Gruppe AG, University Hospital Bern20 recruiting
Oregon Health and Science University20 recruiting
Brigham and Women's Hospital21 recruiting
IRCCS San Camillo, Venezia, Italy22 recruiting
Cairo University20 recruiting
Cinnagen20 recruiting
Geographic activity
United States37trials
Italy14trials
Switzerland12trials
Poland11trials
United Kingdom9trials
Spain9trials
Canada9trials
Czechia7trials
Belgium7trials
France7trials
Portugal7trials
Turkey (Türkiye)7trials
Leading interventions
Ocrelizumab4trials
RPC10632trials
Alcohol Wipes vs. No Alcohol Wipes1trials
All participants will be asked to provide data and samples for collection and analysis.1trials
Antihistamine1trials
Autologous HB-adMSCs1trials
BG9418 (interferon beta-1a)1trials
Avonex prefilled syringe via manual IM injection1trials
BHT-3009-011trials
BIIB0911trials
BIPAMS1trials
Alemtuzumab Injection [Lemtrada]1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.